Feedback Endocrinology

Complications DM – chronic

Mechanisms

  • Non enzymatic glycosylation (NEG)
  • Vascular permeability – sorbitol (polyol pathyway – aldolase)
  • Microvascular occlusions – affects retina, renal, nerve sheath
  • Macrovascular – atherosclerosis (stroke, AMI, diabetic foot)

Diabetic retinopathy

  • Cataracts/EOM palsy (oculomotor, trochlear, abducens)
  • Fundus findings
    • Blot haemorrhages, hard exudates, cotton wool spots, micro aneurysms, macular edema
  • Sudden vision loss – vitreous haemorrhage
  • Ischemia stimulates VEGF > non proliferative/proliferative

Treatment

  • Depends on grading
  • Ranibizumab (VEGF inhibitor), vitrectomy

Nephropathy

  • Please check diabetic nephropathy and chronic glomerulonephritis for detailed information
  • Thickening of glomerular basement membrane and matrix deposits in mesangium > glomerulosclerosis/renal failure
  • Sequence of events –   Microalbuminuria > proteinuria > Nephrotic syndrome
  • Mesangial hypertrophy due to increase glomerular filtration rate (afferent/efferent dilation)

Diagnosis

  • ACR <2.5 (males), <3.5 (females) , mid-stream urine

Neuropathy

  • Occlusion of vasa-nevorum  Sorbitol  > delayed nerve conduction
  • Somatic and autonomic neuropathy

Types

  • Symmetrical sensory polyneuropathy – altered pain and temperature
  • Asymmetric motor neuropathy – weakness, wasting, cachexia
  • Mononeuritis – CN3/6 – diplopia, sciatica, median nerve (carpal tunnel)
  • Autonomic
    • Vagus – postural hypotension, tachycardia
    • Dysphagia, constipation, gastroparesis
    • Bladder – incontinence, atonic, UTI, erectile dysfunction
Diabetic foot
  • Combination of peripheral vascular disease and neuropathy following trauma
Feedback